Pharmacotherapy of adolescent attention deficit hyperactivity disorder: Challenges, choices and caveats

Journal of Psychopharmacology

Volumn 12, Issue 4, 1998, Pages 385-395

  Garland, E Jane ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Adolescence; Amphetamines; Antidepressive agents; Attention deficit disorder with hyperactivity; Methylphenidate; Pemoline

Indexed keywords

AMFEBUTAMONE; DEXAMPHETAMINE; METHYLPHENIDATE; NICOTINE; PEMOLINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANXIETY; ATTENTION DEFICIT DISORDER; COMORBIDITY; DRUG EFFICACY; DRUG SAFETY; PRIORITY JOURNAL; REVIEW;

EID: 0031798071     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119801200410     Document Type: Review

References (130)

1. Abikoff H, Gittelman R (1985) Hyperactive children treated with stimulants: is cognitive training a useful adjunct? Archs Gen Psychiat 42: 953-961
2. Adler L A, Resnick S, Kunz M, Devinsky O (1995) Open label trial of venlafaxine in adults with attention deficit disorder. Psychopharmac Bull 31: 785-788
3. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
4. Arnold L E, Abikoff H B, Cantwell D P, Connors K, Elliott G, Greenhill L L, Hechtman L, Hinshaw S P, Hoza B, Jensen P S, Kraemer H C, March J S, Newcorn J H, Pelham W E, Richters J E, Schiller E, Severe J B, Swanson J M, Vereen D, Wells K C (1997) National Institute of Mental Health collaborative multimodal treatment study of children with ADHD (the MTA). Design challenges and choices. Archs Gen Psychiat 54: 865-870
5. Barkley R A, DuPaul G J, McMurray M B (1990a) A comprehensive evaluation of attention deficit disorder with and without hyperactivity as defined by research criteria. J Consult Clin Psychol 58: 775-789
6. Barkley R A, Fischer M, Edelbrook C S, Smallish L (1990b) The adolescent outcome of hyperactive children diagnosed by research criteria: I. an 8 year prospective follow-up study. J Am Acad Child Adolesc Psychiat 29: 546-557
7. Barkley R A, DuPaul G J, McMurray M B (1991) Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate. Pediatrics 87: 519-531
8. Barrickman L, Noyes R, Kuperman S (1991) Treatment of ADHD with fluoxetine: a preliminary trial. J Am Acad Child Adolesc Psychiat 30: 762-767
9. Barrickman L L, Perry P J, Allen A J, Kuperman S, Arndt S V, Herrmann K J, Schumacher E (1995) Bupropion vs methylphendiate in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiat 34: 649-657
10. Baumgaertel A, Wolraich M L Dietrich M (1995) Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample. J Am Acad Child Adolesc Psychiat 34: 629-638
11. Berkovitch M, Pope E, Phillips J, Koren G (1995) Pemoline-associate fulminant liver failure: testing the evidence for causation. Clin Pharmac Ther 57: 696-698
12. Biederman J, Baldesarini R, Wright V, Knee D, Harmatz J (1989) A double-blind placebo controlled study of desipramine in the treatment of attention deficit disorder. I. Efficacy J Am Acad Child Adolesc Psychiat 28: 777-784
13. Biederman J, Newcorn J, Sprich S (1991) Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety and other disorders. Am J Psychiatr 148: 564-577
14. Biederman J, Thisted R A, Greenhill L L, Ryan N D (1995a) Estimation of the association between desipramine and the risk for sudden death in 5 to 14 year old children. J Clin Psychiat 56: 87-93
15. Biederman J, Wilens T, Mick E, Milberger S, Spencer T J, Faraone SV (1995b) Psychoactive substance abuse disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiat 152:1652-1658
16. Biederman J, Faraone S, Milberger S, Guite J, Mick E, Chen L et al. (1996a) A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Archs Gen Psychiat 53: 437-446
17. Biederman J, Faraone S, Mick et al. (1996b) Attention-defict hyperactivity disorder and juvenile mania: an overlooked comorbidity? J Am Acad Child Adolesc Pscychiatry 35: 997-1008
18. Biederman J, Wilens T, Mick E, Faraone S V, Weber W, Curtis S, Thornell A, Pfister K, Jetton J G, Soriano (1997) Is ADHD a risk factor for psychoactive substance abuse disorders? Findings from a four-year prospective follow-up study. J Am Acad Child Adolesc Psychiat 36: 21-29
19. Buitelaar J K, Van der Gaag R J, Swaab-Barneveld H Kuiper M (1996) Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side effects. J Child Psychol Psychiat Allied Disc 37: 587-967
20. Campbell S B, Douglas V I, Morgenstern G (1971) Cognitive styles in hyperactive children and the effect of methylphendiate. J Child Psychol Psychiat 12: 55-67
21. Campbell M, Adams P B, Small A M, Kafantaris V, Silva R R, Shell J, Perry R, Overall J E (1995) Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo controlled study. J Am Acad Child Adolesc Psychiat 34: 445-453
22. Cantwell D P (1996) Attention deficit disorder: a review of the past 10 years. J Am Acad Child Adolesc Psychiat 35: 978-987
23. Cantwell D P, Swanson J, Connor D (1997) Case study: adverse response to clonidine. J Am Acad Child Adolesc Psychiat 36: 539-544
24. Casat C D, Pleasants D Z, Van Wyk Fleet J (1987) A double-blind trial of bupropion in children with attention deficit disorder. Psychopharmac Bull 23: 198-20
25. Castellanos F X (1997) Neuroimaging of attention deficit hyperactivity disorder. Child Adolesc Psychiat Clin N Am 6: 383-411
26. Castellanos F X, Giedd J N, Elia J, Marsh W L, Ritchie G F, Hamburger S D, Rapoport J L (1997) Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose. J Am Acad Child Adolesc Psychiat 36: 589-596
27. Clay T H, Gualtieri C T, Evans R W, Guillion C M (1988) Clinical and neuropsychological effects of the novel antidepressant bupropion. Psychopharmac Bull 23: 120-122
28. Conners C K (1969) A teacher rating scale for use in drug studies with children. Am J Psychiat 126: 884-888
29. Conners C K (1985) The computerized continuous performance test. Psychopharmac Bull 21: 891-892
30. Conners C K, Taylor E (1980) Pemoline, methylphenidate and placebo in children with minimal brain dysfunction. Archs Gen Psychiat 37: 922-932
31. Conners C K, Taylor E, Meo G, Kurtz M A, Fournier M (1972) Magnesium pemoline and dextroamphetamine: a controlled study in children with minimal brain dysfunction. Psychopharmacologia 26: 321-336
32. Conners C K, Casat C D, Gualtieri T, Weller E, Reader M, Reiss A, Weller R A, Khayrallah M, Ascher J (1996a) Bupropion hypdrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiat 35: 1314-1321
33. Conners C K, Levin E D, Sparrow E, Hinton S C, Erhardt D, Meck W H, Rose J E, March J (1996b) Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmac Bull 32: 67-73
34. Cromer B A, Tarnowski (1989) Noncompliance in adolescents: a review. Dev Behav Pediat 10: 207-215
35. Cueva J E, Overall J E, Small A M, Armenteros J L, Perry R, Campbell M (1996) Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiat 35: 480-490
36. Denckla M B (1996) Biological correlates of learning and attention: what is relevant to learning disability and attention-deficit hyperactivity disorder? J Dev Behav Pediat 17: 114-119
37. Diller L H (1996) The run on Ritalin: attention deficit disorder and stimulant treatment in the 1990s. Hastings Center Rep 26: 12-18
38. Douglas V I, Barr R G, Desilets J, Sherman E (1995) Do high doses of stimulants impair flexible thinking in attention-defict hyperactivity disorder? J Am Acad Child Adolesc Psychiat 34: 877-885
39. Elia J, Borcherding B, Rapoport J, Keysor C (1991) Methylphenidate and detroamphetamine treatments of hyperactivity: are there true nonresponders? Psychiat Res 36: 141-155
40. Feigin A, Kurlan R, McDermott M P, Beach J et al. (1996) A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder. Neurology 46: 965-968
41. Friedmann N, Thomas J, Carr R, Elders J, Ringdahl I, Roche A (1981) Effect on growth in pemoline-treated children with attention deficit disorder. Am J Dis Child 135: 329-332
42. Gadow K D, Nolan E E, Sverd J, Sprafkin J, Paolicelli L (1990) Methylphenidate in aggressive-hyperactive boys. I. Effects on peer aggression in public school settings. J Am Acad Child Adolesc Psychiat 29: 710-718
43. Gadow K D, Nolan E, Sprafkin J, Sverd J (1995a) School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment. J Dev Behav Pediat 16: 167-176
44. Gadow K D, Sverd J, Sprafkin J, Nolan E, Ezor S N (1995b) Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Archs Gen Psychiatry 52: 444-455
45. Gammon G D, Brown T E (1993) Fluoxetine augmentation of methylphenidate for attention deficit and comorbid disorders. J Child Adolesc Psychopharmac 3: 1-10
46. Gillberg C, Melander H, von Knorring A-L, Janols L-O, Thernlund G, Hagglof B, Eidevall-Wallin L, Gustafsson P, Kopp S. (1997) Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms. Archs Gen Psychiat 54: 857-864
47. Gittelman R, Abikoff H, Pollack E, Klein D F, Katz S, Mattes J (1980) Behavior therapy and methylphenidate for hyperactive children. In Whalen C K, Henker B, (eds), Hyperactive children: the social ecology of identification and treatment. Academic Press, New York, pp. 221-243
48. Greenhill L L, Abikoff H B, Arnold L E, Cantwell D P, Conners C K, Elliott G, Hechtman L, Hinshaw S P, Hoza B, Jensen P S, March J S, Newcorn J, Pelham W E, Severe J B, Swanson J M, Vitiello B, Wells K (1996) Medication treatment strategies in the MTA study: relevance to clinicians and researchers. J Am Acad Child Adolesc Psychiat 35: 1304-1313
49. Gwirtsman H E, Szuba M P, Toren L, Feist M (1994) The antidepressant response to tricyclics in major depressives is accelerated with adjunctive use of methylphenidate. Psychopharmac Bull 30: 157
50. Hedges D, Reimherr F W, Rogers A, Strong R, Wender P H (1995) An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder. Psychopharmac Bull 31: 779-783
51. Hinshaw S P, Heller T, McHale J P (1992) Covert antisocial behavior in boys with attention-deficit hyperactivity disorder: external validation and effects of methylphendiate. J Consult Clin Psychol 60: 274-281
52. Horn W R, Ialongo N S, Pascoe J M, Greenberg G, Packard T, Lopez M, Wagner A, Puttler L (1991) Additive effects of psychostimulants, parent training, and self-control therapy with ADHD children. J Am Acad Child Adolesc Psychiat 30: 233-240
53. Hunt R D (1987) Treatment effects of oral and transdermal clonidine in relation to methylphendiate - an open pilot study in ADHD. Psychopharmac Bull 23: 111-114
54. Hunt R D, Minderaa R B, Cohen D J (1985) Clonidine benefits children with attention deficit disorder and hyperactivity: report of a double-blind placebo-crossover therapeutic trial. J Am Acad Child Adolesc Psychiat 24: 617-629
55. Hunt R D, Arnsten A F T, Asbell M D (1995) An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatr 34: 50-54
56. Ialongo N S, Horn W F, Pascoe J M, Greenberg G, Packard et al. (1993) The effects of a multimodal intervention with attention deficit hyperactivity disorder children: a 9 month follow-up. J Am Acad Child Adolesc Psychiat 32: 182-189
57. Jacobvitz D, Sroufe L A, Stewart M, Leffert N (1990) Treatment of attentional and hyperactivity problems in children with sympathomimetic drugs: a comprehensive review. J Am Acad Child Adolesc Psychiat 29: 677-688
58. Jaffe S L (1991) Intranasal abuse of prescribed methylphendiate by an alcohol and drug abusing adolescent with ADHD. J Am Acad Child Adolesc Psychiat 30: 774-775
59. Johnson A, Guiffre R M, O'Malley K (1996) ECG changes in pediatric patients on tricyclic antidepressants, desipramine and imipramine. Can J Psychiat 41: 102-106
60. Johnston J A, Lineberry C G, Ascher J A et al. (1991) A 102-center prospective study of seizures in assocation with bupropion. J Clin Psychiat 52: 450-456
61. Jureidini J (1996) Some reasons for concern about attention deficit hyperactivity disorder. J Pediatr Child Hlth 32: 201-203
62. Kent J D, Blader J C, Koplewicz H S, Abikoff H, Foley C A (1995) Effects of late-afternoon methylphenidate administration on behavior and sleep in attention-deficit hyperactivity disorder. Pediatrics 96: 320-325
63. Kutcher, S. (1997). Child and adolescent psychopharmacology. W B Saunders, Philadelphia, PA, pp. 273-294
64. Langer D H, Sweeney K P, Bartenbach D E, Davis P M, Menander K B (1986) Evidence of lack of abuse or dependence following pemoline treatment: results of a retrospective survey. Drug Alcohol Depend 17: 213-227
65. Leung P W, Luk S L, Ho T P, Taylor E, Mak F L, Bacon-Shone J (1996) The diagnosis and prevalence of hyperactivity in Chinese school-boys. Brit J Psychiat 168: 4860-496
66. Levin E D, Conners C K, Sparrow E, Hinton S C, Erhardt D, Meck W H, Rose JE, March J (1996) Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology 123: 55-63
67. Levy F, Hobbes G (1996) Does haloperidol block methylphenidate? Motivation or attention? Psychopharmacology 126: 70-74
68. Levy F, Hay D A, McStephen M, Wood C, Waldman I (1997) Attention-deficit hyperactivity disorder: a category or a continuum? Genetic analysis of a large-scale twin study. J Am Acad Child Adolesc Psychiat 36: 737-744
69. Mattes J (1980) A pilot trial of amantadine in hyperactive children. Psychopharmac Bull 16: 67-69
70. Milberger S, Biederman J, Faraone S V, Chen L, Jones J (1997) ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiat 36: 37-44
71. Murphy D, Pelham W, Lang A (1992) Aggression in boys with ADHD. Methylphenidate effects on naturalistically observed aggression, response to provocation and social information processing. J Abnorm Child Psychol 20: 451-466
72. Nada-Raja S, Langley J, McGee R, Williams S M, Begg D J, Reeder A I (1997) Inattentive and hyperactive behaviors and driving offences in adolescence. J Am Acad Child Adolesc Psychiat 36: 515-522
73. Nolan E E, Gadow K D (1997) Children with ADHD and tic disorder and their classmates: behavioral normalization with methylphendiate. J Am Acad Child Adolesc Psychiat 36: 597-604
74. Pataki C, Carlson G, Kelly K, Rapport M, Biancaniello T (1993) Side effects of methylphenidate and desipramine alone and in combination in children. Am J Psychiat 32: 1065-1072
75. Parran T V, Jasinski D R (1991) Intravenous methylphenidate abuse. Prototype for prescription drug abuse. Arch Int Med 151: 781-783
76. Pelham W E, Bender M e, Caddell J, Booth S, Moorer S A (1985) Methylphenidate and children with attention deficit disorder: dose effects on classroom academic and social behavior. Arch Gen Psychiat 42: 948-952
77. Pelham W E, Sturges J, Hoza J, Schmidt C, Bijlsma J J, Milich R, Moorer S (1987) Sustained release and standard methylphendiate effects on cognition and social behavior in children with attention deficit disorder. Pediatrics 80: 491-501
78. Pelham W E, Walker J L, Sturges, J Hoza J (1989) Comparative effects of methylphenidate on ADD girls and boys. J Am Acad Child Adolesc Psychiat 28: 773-776
79. Pelham W, Greenslade K, Vodde-Hamilton M et al. (1990) Relative efficacy of long-acting stimulants on children with attention deficit-hyperactivity disorder: a comparison of standard methylphenidate, sustained release methylphenidate, sustained release dextroamphetamine and pemoline. Pediatrics 86: 226-237
80. Pelham W E, Vodde-Hamilton M, Murphy D A, Greenstein J, Vallano G (1991) The effects of methylphenidate on ADHD adolescents in recreational, peer group and classroom settings. J Clin Child Psychol 20:293-300
81. Pelham W E, Swanson J M, Furman M B, Schwindt H (1995) Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures. J Am Acad Child Adolesc Psychiat 34: 1504-1513
82. Pizzuti D (1996) Letter to physicians. Abbott Laboratories Pharmaceutical Products Divison, Medical Services Department, Abbott Park, Chicago, IL, USA
83. Pliszka S R (1989) Effect of anxiety on cognition, behavior, and stimulant response in ADHD. J Am Acad Child Adolesc Psychiat 28: 882-887
84. Pliszka S R, McCracken J T, Maas J W (1996) Catecholamines in attention-deficit hyperactivity disorder: current perspectives. J Am Acad Child Adolesc Psychiat 35: 264-272
85. Pratt D S, Dubois R S (1990) Hepatotoxicity due to pemoline: a report of two cases. J Pediatr Gastroenterol Nutr 10: 239-241
86. Prendergast N, Taylor E, Rapoport J L, Bartko J, Donnelly M, Zametkin A, Ahearn M B, Dunn G Wieselberg H M (1988) The diagnosis of childhood hyperactivity: a US-UK cross-national study of DSMIII and ICD-9. J Child Psychol Psychiat 35: 599-605
87. Priest R G, Gimbrett R, Roberts N, Steinart (1995) Reversible and selective inhibitors of monoamine oxidase in mental and other disorders. Acta Psychiat Scand 386 (Suppl): 40-43
88. Prince J B, Wilens T E, Biederman J, Spencer T J, Wozniak J R (1996) Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder: a systematic chart review of 62 cases. J Am Acad Child Adoles Psychiat 35: 599-605
89. Rapoport J L, Quinn P, Bradbard G, Riddle D, Brooks E (1974) Imipramine and methylphenidate treatment of hyperactive boys: a double-blind comparison. Archs Gen Psychiat 30: 789-793
90. Rapoport J L, Buchsbaun M S, Zahn T P, Weingartner H, Ludlow C, Mikkelsen E J (1978) Dextroamphetamine: cognitive and behavioral effects in normal prepubertal boys. Science 199: 560-563
91. Rapport M, Denney C, DuPaul G J, Gardner M J (1994) Attention deficit disorder and methylphenidate: normalization rates, clinical effectiveness, and response prediction in 76 children. J Am Acad Child Adolesc Psychiat 33: 882-893
92. Riddle M A, King R A, Hardin M T et al. (1991) Behavioral side effects of fluoxetine in children and adolescents. J Child Adolesc Psychopharmac 1: 193-198
93. Riddle M A, Geller B, Ryan N D (1994) The safety of desipramine. J Am Acad Child Adolesc Psychiat 33: 589-590
94. Riggs P D (1998) Clinical approach to treatment of ADHD in adolescents with substance abuse disorders and conduct disorder. J Am Acad Child Adolesc Psychiat 37: 331-332
95. Riggs P D, Thompson L L, Mikulich S K, Whitmore E A, Crowley T J (1996) An open trial of pemoline in drug-dependent delinquents with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiat 35: 1018-1024
96. Robbins T W, Everitt B J (1996) Neurobehavioral mechanisms of reward and motivation. Curr Opin Neurobiol 6: 228-236
97. Safer D J, Allen R P (1975) Stimulant drug treatment of hyperactive adolescents. Dis Nerv Sys 36: 454-457
98. Safer D J, Krager J M (1994) The increased rate of stimulant treatment for hyperactive/inattentive students in secondary schools. Pediatrics 94: 462-464
99. Safer D J, Zito J M, Fine E M (1996) Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 98: 1084-1088
100. Satterfield J H, Satterfield B T, Schell A M (1987) Therapeutic interventions to prevent delinquency in hyperactive boys. J Am Acad Child Adolesc Psychiat 26: 56-64
101. Schachar R, Hoppe C, Schell A (1987) Changes in family function and relationships in children who respond to methylphendiate. J Am Acad Child Adoles Psychiat 26: 728-732
102. Schachar R J, Tannock R, Cunningham C, Corkum P V (1997) Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate. J Am Acad Child Adolesc Psychiat 36: 754-763
103. Schweitzer J B, Sulzer-Azaroff B (1994) Self-control in boys with attention deficit hyperactivity disorder: effects of added stimulation and time. J Child Psychol Psychiat 36: 671-686
104. Sherman D K, McGue M K, Iacono W G (1997) Twin concordance for attention deficit hyperactivity disorder: a comparison of teachers' and mothers' reports. Am J Psychiat 154: 532-535
105. Simeon J G, Ferguson H B, Van-Wyck-Fleet J (1986) Bupropion effects in attention deficit and conduct disorders. Can J Psychiat 31: 581-585
106. Silva R R, Munoz D M, Alpert M (1996) Carbamazepine use in children and adolescents with features of attention-deficit hyperactivity disorder: a meta-analysis. J Am Acad Child Adoles Psychiat 35: 352-358
107. Smith, B H, Pelham W E, Gnagy E, Yudell, R S (1998) Equivalent effects of stimulant treatment for attention-deficit hyperactivity disorder during childhood and adolescence. J Am Acad Child Adolesc Psychiat 37: 314-321
108. Sonuga-Barke E F S, Taylor E, Sembi S, Smith J (1992) Hyperactivity and delay aversion: 1. the effect of delay on choice. J Child Psychol Psychiat 32: 909-938
109. Spencer T, Wilens T, Biederman J, Faraone S V, Ablon S, Lapey K (1995) A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Archs Gen Psychiat 52: 434-443
110. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S (1996a) Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiat 35: 409-432
111. Spencer T J, Biederman J, Harding M, O'Donnell D. Faraone S V Wilens T E (1996b) Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays? J Am Acad Child Adolesc Psychiat 35: 1460-1469
112. Sprague R, Sleator E (1977) Methylphenidate m hyperkinetic children: differences in dose effects on learning and social behavior. Science 198: 1274-1276
113. Stein M A, Blondis R A, Schnitzler E R, O'Brien T, Fishkin J, Blackwell B (1996) Methylphendiate dosing: twice daily versus three times daily. Pediatrics 98: 748-756
114. Stoll A L, Pillay S S, Diamond L, Workum S B, Cole J O (1996) Methylphenidate augmentation of serotonin selective reuptake inhibitors: a case series. J Clin Psychiat 56: 72-76
115. Swanson J M, Flockart D, Udrea D, Cantwell D P, Connor D, Williams L (1995) Clonidine in the treatment of ADHD: questions about safety and efficacy. J Child Adolesc Psychopharmac 5: 301-304
116. Tannock R, Schachar R, Logan G (1995a) Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children. J Abnorm Child Psychol 23: 235-266
117. Tannock R, Ichowica A, Schachar R (1995b) Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety. J Am Acad Child Adolesc Psychiat 34: 886-896
118. Teicher M H, Ito Y, Glod C A, Barber N I (1996) Objective measurement of hyperactivity and attentional problems in ADHD. J Am Acad Child Adolesc Psyuchiat 35: 334-342
119. Trott G E. Friese H J, Menzel M, Nissen G (1991) Use of moclobemide in children with attention deficit hyperactivity disorder. Jugendpsychiat 19: 248-253 (in German)
120. Varley C (1983) Effects of methylphenidate in adolescents with attention defciti disorder. J Am Acad Child Adolesc Psychiat 22: 351-354
121. 2 receptors. Am J Psychiat 154: 50-55
122. Warburton D M, Arnall C (1994) Improvements in performance without nicotine withdrawal. Psychopharmac 115: 539-542
123. Weiss G, Hechtman LT (1993) Hyperactive children grown up, 2nd edn. Guildford Press, New York
124. Werry J S (1994) The safety of desipramine. J Am Acad Child Adolesc Psychiat 33: 588-589
125. Whalen C, Hencker B, Swanson J, Granger D (1990) Social judgement processes in hyperactive boys: effects of methylphendiate and comparisons with normal peers. J Abnorm Child Psychol 18: 297-316
126. Wilens T, Biederman J, Spencer T, Prince J (1995) Pharmacotherapy of adult attention deficit hyperactivity disorder: a review. J Clin Psychopharmac 15: 270-279
127. Wilens T E, Biederman J, Spencer TJ (1997) Adverse effects of smoking marijuana while receiving tricyclic antidepressants. J Am Acad Child Adolesc Psychiat 36: 45-48
128. Wolraich M L, Hannah J N, Pinnock T Y, Baumgartel A, Brown J (1996) Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiat 35: 319-324
129. World Health Organization (1992) The ICD-10 classification of mental and behavioral disorders: clinical descriptions and diagnostic guidelines. World Health Organization, Geneva
130. Zametkin, A J, Rapoport J L, Murphy D (1986) Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy. Archs Gen Psychiat 42: 962-966